500 ITP patients under the microscope: what real clinics reveal about treatment
NCT ID NCT07268898
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will review medical records of 500 people with newly diagnosed or persistent immune thrombocytopenia (ITP) across multiple hospitals in China. Researchers will look at what treatments patients actually received and how well they worked, without influencing their care. The goal is to map the current treatment landscape and identify patterns that could guide better management of ITP.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors understand which treatments work best for ITP in everyday practice, potentially improving care guidelines.
What could go wrong
This is an observational study that only looks back at existing records, so it cannot prove cause and effect. Results may not apply to all patients or regions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA (ITP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.